Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
Excluding Normal Battery Depletion – This is the malfunction free survival curve.
*The second longevity numbers provided apply to the N-series Adapta ADSR06 product. The N-series products have increased longevity because of improved electronic circuitry. Click on "Other Articles" for more information on the N-series longevity.
Longevity estimates based on the following device usage.
Pace/Sense Mode VVI ;
Right Ventricle Pulse Width 0.4 ms;
Lower Pace Rate 60 bpm;
Right Ventricle Percent Paced 100 %;
EGM Prestorage ON ;
Upper Sensing Rate 130 ppm;
EGM Prestorage ON Time 1 ;
Hide this content
Distribution Data
US Market Release
2006-07-17
CE Approval Date
2005-09-20
Registered USA Implants
2894
Estimated Active USA Implants
687
Normal Battery Depletions
236
US Market Release
2006-07-17
CE Approval Date
2005-09-20
Estimated WW Distribution
10624
Normal Battery Depletions
313
Malfunctions (USA)
Therapy Function Not Compromised
2
Electrical Component
2
Therapy Function Compromised
0
Malfunctions (WW)
Therapy Function Not Compromised
2
Electrical Component
2
Therapy Function Compromised
0
EOS Indication
From the point that the ERI is set, the pacemaker will operate at ERI conditions for approximately three months for typical pacemaker configurations during the normal operating life.
Recommended Replacement (RRT)
Telemetry indication. Rate and mode change to 65 ppm and VVI respectively (VOO/65 with magnet).
